Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Ali Alavianmehr
Observed name:
Ali Alavian-Mehr
Institution:
Shiraz University of Medical Sciences
Observed institution:
Shiraz University of Medical Sciences
ORCID:
0000-0002-0166-2597
Observed ORCID:
0000-0002-0166-2597
OpenAlex ID:
A5060766808
PD-L1 expression in tumor lesions and soluble PD-L1 serum levels in patients with breast cancer: TNBC versus TPBC
2021
·
Parvaneh Yazdanpanah
, Ali Alavianmehr
, et al.
·
Breast Disease
·
18
Impact of donor KIRs and recipient KIR/HLA class I combinations on GVHD in patients with acute leukemia after HLA-matched sibling HSCT
2020
·
Marzieh Mansouri
, Jean Villard
, et al.
·
Human Immunology
·
9
Eugenol: A New Option in Combination Therapy with Sorafenib for the Treatment of Undifferentiated Thyroid Cancer
2022
·
Pedram Talezadeh Shirazi
, Shirin Farjadian
, et al.
·
Iranian Journal of Allergy Asthma and Immunology
·
8
Association of killer‐cell immunoglobulin‐like receptor genes with acute myelogenous leukaemia
2020
·
Ali Alavianmehr
, Marzieh Mansouri
, et al.
·
International Journal of Immunogenetics
·
7
HLA-G: Facts and Fictions
2018
·
Parisa Khodabandeh Shahraki
, Ali Alavian-Mehr
, et al.
·
Asian Pacific Journal of Cancer Biology
·
6
PDF
Sequential radiation exposure: uncovering the potential of low dose ionizing radiation in mitigating high dose effects on immune cells
2024
·
Sadegh Masoudi
, Mehdi Kalani
, et al.
·
International Journal of Radiation Biology
·
2
Show more works
View as search
Works count:
6
Citation count:
50
H-index:
5
I10-index:
1
Year
Topic
Type